QSAR Studies on ABC Transporter – How to Deal with Polyspecificity

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  2009-10-14

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1002/9783527627424.CH7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009cited by this paper
• Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors

  2008cited by this paper
• Similarity‐Based Descriptors (SIBAR) as Tool for QSAR Studies on P‐Glycoprotein Inhibitors: Influence of the Reference Set

  2007cited by this paper
• Multispecificity of Drug Transporters: Probing Inhibitor Selectivity for the Human Drug Efflux Transporters ABCB1 and ABCG2

  2007cited by this paper
• Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.

  2006cited by this paper
• P-glycoprotein recognition of substrates and circumvention through rational drug design.

  2006cited by this paper
• High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis.

  2006cited by this paper
• Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).

  2005cited by this paper
• Role of the breast cancer resistance protein (ABCG2) in drug transport

  2005cited by this paper
• Estimation of the Three-Dimensional Pharmacophore of Ligands for Rat Multidrug-Resistance–Associated Protein 2 Using Ligand-Based Drug Design Techniques

  2005cited by this paper
• Inhibitors of multidrug efflux transporters: their membrane and protein interactions.

  2005cited by this paper
• An in silico approach for screening flavonoids as P-glycoprotein inhibitors based on a Bayesian-regularized neural network

  2005cited by this paper
• Anticancer multidrug resistance mediated by MRP1: Recent advances in the discovery of reversal agents

  2005cited by this paper
• Quantitative structure-activity relationships of methotrexate and methotrexate analogues transported by the rat multispecific resistance-associated protein 2 (rMrp2).

  2005cited by this paper
• Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance.

  2005cited by this paper
• Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.

  2005cited by this paper
• Inhibitors of p-glycoprotein--lead identification and optimisation.

  2005cited by this paper
• Intramolecular Distribution of Hydrophobicity Influences Pharmacological Activity of Propafenone‐type MDR Modulators

  2004cited by this paper
• Combinatorial QSAR of Ambergris Fragrance Compounds

  2004cited by this paper
• Inhibitors of ABC-type drug efflux pumps: an overview of the current patent situation

  2004cited by this paper
• Lead Identification for Modulators of Multidrug Resistance based on in silico Screening with a Pharmacophoric Feature Model

  2004cited by this paper
• Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

  2003cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).

  2002cited by this paper
• Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.

  2002cited by this paper
• Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.

  2002cited by this paper
• ABC transporters and inhibitors: new targets, new agents.

  2002cited by this paper
• Similarity based SAR (SIBAR) as tool for early ADME profiling

  2002cited by this paper
• A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.

  2002cited by this paper
• Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.

  2002cited by this paper
• Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines.

  2001cited by this paper
• Structure-activity relationships of multidrug resistance reversers.

  2001cited by this paper
• Artificial Neural Networks in Drug Design 11: Influence of Learning Rate and Momentum Factor on the Predictive Ability

  2000cited by this paper
• Estimation of active conformations of drugs by a new molecular superposing procedure

  1999cited by this paper
• The importance of a nitrogen atom in modulators of multidrug resistance.

  1999cited by this paper
• Artificial neural networks as versatile tools for prediction of MDR-modulatory activity.

  1999cited by this paper
• Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.

  1998cited by this paper
• A Combined Hansch/Free‐Wilson Approach as Predictive Tool in QSAR Studies on Propafenone‐Type Modulators of Multidrug Resistance

  1998cited by this paper
• A Comparative Molecular Field Analysis of Propafenone‐type Modulators of Cancer Multidrug Resistance

  1998cited by this paper
• Studies on Propafenone‐type Modulators of Multidrug Resistance III: Variations on the Nitrogen

  1997cited by this paper
• Structure−Activity Relationship Studies on Benzofuran Analogs of Propafenone-Type Modulators of Tumor Cell Multidrug Resistance

  1996cited by this paper
• Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.

  1996cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

  1981cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Integrated Application of Enhanced Replacement Method and Ensemble Learning for the Prediction of BCRP/ABCG2 Substrates

  2017cites this paper
• Antimicrobial and Immunosuppressive Activitities of Cyclopeptides as Targets for Medicinal Chemistry

  2016cites this paper
• Development of Conformation Independent Computational Models for the Early Recognition of Breast Cancer Resistance Protein Substrates

  2013influential citation
• Prediction of Promiscuous P-Glycoprotein Inhibition Using a Novel Machine Learning Scheme

  2012cites this paper
• Molecular basis of drug-P-glycoprotein interaction

  2012cites this paper
• Exhaustive Sampling of Docking Poses Reveals Binding Hypotheses for Propafenone Type Inhibitors of P-Glycoprotein

  2011cites this paper